These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

714 related items for PubMed ID: 25700931

  • 1. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.
    Bech AP, Bouma-de Krijger A, van Zuilen AD, Bots ML, van den Brand JA, Blankestijn PJ, Wetzels JF, Vervloet MG.
    J Nephrol; 2015 Aug; 28(4):477-84. PubMed ID: 25700931
    [Abstract] [Full Text] [Related]

  • 2. Association of combined fractional excretion of phosphate and FGF23 with heart failure and cardiovascular events in moderate and advanced renal disease.
    Mendonça L, Bigotte Vieira M, Neves JS.
    J Nephrol; 2023 Jan; 36(1):55-67. PubMed ID: 35678953
    [Abstract] [Full Text] [Related]

  • 3. Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
    De Jong MA, Eisenga MF, van Ballegooijen AJ, Beulens JWJ, Vervloet MG, Navis G, Gansevoort RT, Bakker SJL, De Borst MH.
    Nephrol Dial Transplant; 2021 Jan 01; 36(1):121-128. PubMed ID: 32124925
    [Abstract] [Full Text] [Related]

  • 4. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
    Mehta R, Ying GS, Houston S, Isakova T, Nessel L, Ojo A, Go A, Lash J, Kusek J, Grunwald J, Wolf M, CRIC Study Investigators.
    Nephrol Dial Transplant; 2015 Sep 01; 30(9):1534-41. PubMed ID: 25910495
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes.
    Dominguez JR, Shlipak MG, Whooley MA, Ix JH.
    J Am Soc Nephrol; 2013 Mar 01; 24(4):647-54. PubMed ID: 23520205
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
    de Borst MH, Baia LC, Hoogeveen EK, Giltay EJ, Navis G, Bakker SJL, Geleijnse JM, Kromhout D, Soedamah-Muthu SS.
    Nutrients; 2017 Nov 11; 9(11):. PubMed ID: 29137111
    [Abstract] [Full Text] [Related]

  • 15. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI, Maestro ML, Pérez-Flores I, Valero R, Rafael S, Veganzones S, Calvo N, De la Orden V, De la Flor JC, Valga F, Vidaurreta M, Fernández-Pérez C, Barrientos A.
    Nephrol Dial Transplant; 2012 Nov 11; 27(11):4227-35. PubMed ID: 23144073
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
    Dhayat NA, Ackermann D, Pruijm M, Ponte B, Ehret G, Guessous I, Leichtle AB, Paccaud F, Mohaupt M, Fiedler GM, Devuyst O, Pechère-Bertschi A, Burnier M, Martin PY, Bochud M, Vogt B, Fuster DG.
    Kidney Int; 2016 Sep 11; 90(3):648-57. PubMed ID: 27370409
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial.
    Ix JH, Isakova T, Larive B, Raphael KL, Raj DS, Cheung AK, Sprague SM, Fried LF, Gassman JJ, Middleton JP, Flessner MF, Block GA, Wolf M.
    J Am Soc Nephrol; 2019 Jun 11; 30(6):1096-1108. PubMed ID: 31085679
    [Abstract] [Full Text] [Related]

  • 20. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
    Shardlow A, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW.
    BMJ Open; 2017 Aug 23; 7(8):e016528. PubMed ID: 28838895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.